J&J gets out of diagnostics

Share this article:

Johnson & Johnson is offloading its Ortho Diagnostics business for $4 billion. The company announced Monday that it accepted the Carlyle Group's January offer to take on the business, which includes in-vitro diagnostic products.

Bloomberg reports that Carlyle expects to run the unit as a standalone business, and that the transaction relieves J&J of its only diagnostics division.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.